PURR
NASDAQ · Biotechnology

Hyperliquid Strategies

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$4.95
+0.07 (+1.43%)
As of Mar 29, 10:18 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +242.4% upside
Low Target $12.34
Average Target $16.95
High Target $26.10
Current Price $4.95
Current
$4.95
Target
$16.95
$12.34 $16.95 avg $26.10
Scenario Analysis
Bear Case
$12.34
149.3%
Low target
Base Case
$16.95
+242.4%
Avg target
Bull Case
$26.10
+427.3%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$6.63
-25.3% from high
52-Week Low
$3.01
+64.5% from low
Target vs 52W High
$16.95
+155.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
 Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -28.5%